Symmetry Medical to Acquire Specialty Surgical Instruments
WARSAW, Ind. -- Symmetry Medical Inc., an independent provider of products to the global orthopedic device industry and other medical markets, announces that it has entered into a definitive agreement to acquire Specialty Surgical Instruments (SSI) and Ultra Containers of America (UCA), a leading provider of specialty surgical instruments and sterilization containers, for $15.1 million in cash on a debt free basis, subject to certain adjustments. Symmetry Medical has also entered into a two-year agreement for a potential earn out with SSI and UCA. The acquisition is expected to close by
Sept. 30, 2007.
SSI, based in Nashville, has a 30-year history of offering targeted sales, marketing and distribution programs to serve the key surgical specialties of neurological, spine, orthopedics, cardiovascular, ENT, laparoscopy and ophthalmology. The company's portfolio includes its own line of Ultra Instruments and includes the UCA - Ultra Container system, a closed container system that is designed to store and transport sterilized instruments. The Ultra Instruments and UCA Ultra Containers are offered through SSI distribution channels and will continue with Symmetry Medical. SSI's Ultra Instruments and Ultra Containers will now be part of Symmetry Medical's standard products. SSI and UCA reported 2006 revenues of approximately $21 million. SSI has an in-house sales staff of 25 representatives.
Brian Moore, president and CEO, stated, "SSI is an excellent strategic fit for Symmetry Medical. This acquisition will be consistent with our long-term efforts to further diversify our business into other medical device markets and helps strengthen our competitive advantage as a Total Solutions(R) provider. SSI's strong distribution channels offer the opportunity to increase our penetration directly into hospitals and deliver additional cross-selling opportunities to our customers. Further, the acquisition will extend Symmetry's product reach into surgical specialties where we previously had limited presence, including cardiovascular, ENT and ophthalmology."
Source: Symmetry Medical Inc.
   .
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
